In this podcast, Jade Parker, Editor of Oncology Central speaks to Dirk Arnold. Prof Arnold is Director of the department of Medical Oncology at Klinik für Tumorbiologie, Freiburg, Germany. Before taking this position, he was 2010 appointed as Director of the University Cancer Centre in Hamburg (UCCH) and held positions at the University Departments for Oncology and Haematology in Halle-Wittenberg and Berlin.

His major field of scientific interest are gastrointestinal cancers and here specifically modern therapeutic approaches in biomarker-driven decision processes and multimodal treatment strategies.

We caught up with Prof Arnold at the ESMO World Congress on Gastrointestinal Cancer 2017 (Barcelona, Spain, 28 June–1 July). In this interview find out about the main treatment options for oligometastic rectal cancer and how we can define a treatment strategy for this disease. Prof Arnold also tells us how he hopes to see the field progress in the next 5-10 years.

 

You might also like